These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7862827)

  • 1. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
    Daly SA; Waddington JL
    Psychopharmacology (Berl); 1993; 113(1):45-50. PubMed ID: 7862827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists.
    Deveney AM; Waddington JL
    Pharmacol Biochem Behav; 1997 Oct; 58(2):551-8. PubMed ID: 9300618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
    Daly SA; Waddington JL
    Br J Pharmacol; 1994 Nov; 113(3):839-44. PubMed ID: 7858875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1989 Feb; 160(3):377-84. PubMed ID: 2565818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
    Daly SA; Waddington JL
    Eur J Pharmacol; 1992 Mar; 213(2):251-8. PubMed ID: 1387846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No change in dopamine D1 receptor in vivo binding in rats after sub-chronic haloperidol treatment.
    Sanci V; Houle S; DaSilva JN
    Can J Physiol Pharmacol; 2002 Jan; 80(1):36-41. PubMed ID: 11911224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
    Deveney AM; Waddington JL
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic effects of isofloxythepin on dopamine D1 and D2 receptors and behaviors in rats.
    Lau YS; Fung YK; Anderson TM
    Gen Pharmacol; 1997 Nov; 29(5):729-36. PubMed ID: 9347318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome.
    Taylor JL; Rajbhandari AK; Berridge KC; Aldridge JW
    Brain Res; 2010 Mar; 1322():92-101. PubMed ID: 20114036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?
    van Kampen J; Stoessl AJ
    Neuropharmacology; 1997; 36(11-12):1679-88. PubMed ID: 9517439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1990 Sep; 186(1):79-86. PubMed ID: 2149339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR; Brooderson RJ; White FJ
    Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural evidence for cholecystokinin-dopamine D1 receptor interactions in the rat.
    Van Kampen J; Frydryszak H; Stoessl AJ
    Eur J Pharmacol; 1996 Feb; 298(1):7-15. PubMed ID: 8867913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
    Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington JL; Koshikawa N
    Eur J Pharmacol; 1999 Feb; 367(2-3):143-9. PubMed ID: 10078986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.